Search for: "Apotex, Inc. v. FDA, et al"
Results 21 - 40
of 71
Sorted by Relevance
|
Sort by Date
18 Apr 2016, 9:58 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
15 Jun 2011, 4:56 am
Apotex Inc. et al. [read post]
18 Aug 2010, 12:19 am
Varam, Inc. et al. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
6 Jul 2010, 5:18 am
" Pfizer Inc. et al v. [read post]
13 Oct 2016, 6:50 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 Sep 2016, 6:03 pm
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
22 Dec 2010, 3:01 am
Mylan Inc. et al. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
14 Nov 2016, 9:16 am
R. 50 JMOL motion) BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
1 Apr 2016, 8:22 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
3 May 2016, 1:42 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 May 2016, 8:19 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
14 Jul 2010, 6:47 pm
Helm et al. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Apotex, Inc. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
17 Mar 2016, 2:45 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
16 Jan 2017, 5:44 pm
Shell Oil Company, et al., No. 16-713 BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
8 Feb 2017, 3:09 am
Shell Oil Company, et al., No. 16-713 BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
